439 related articles for article (PubMed ID: 6759029)
21. New combined oral contraceptive with incremental progestogen dosage regimen.
Brosens I; Van Assche A; Koninckx P; Heyns W; De Hertogh R
Eur J Obstet Gynecol Reprod Biol; 1976; 6(6):315-8. PubMed ID: 1035172
[TBL] [Abstract][Full Text] [Related]
22. Fertility following discontinuation of different methods of fertility control.
Fraser IS; Weisberg E
Contraception; 1982 Oct; 26(4):389-415. PubMed ID: 6759030
[TBL] [Abstract][Full Text] [Related]
23. Benefits and risks of oral contraceptive use.
Williams RS
Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
[TBL] [Abstract][Full Text] [Related]
24. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
25. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
Parsey KS; Pong A
Contraception; 2000 Feb; 61(2):105-11. PubMed ID: 10802275
[TBL] [Abstract][Full Text] [Related]
26. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
27. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
28. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
29. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Belsey EM; d'Arcangues C; Carlson N
Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508
[TBL] [Abstract][Full Text] [Related]
30. Menstrual impact of contraception.
Stubblefield PG
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
[TBL] [Abstract][Full Text] [Related]
31. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Kay CR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
[TBL] [Abstract][Full Text] [Related]
32. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
33. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
34. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
Belsey EM; Peregoudov S
Contraception; 1988 Aug; 38(2):227-42. PubMed ID: 2971507
[TBL] [Abstract][Full Text] [Related]
35. Instructions for minipill users.
Reese M; Hatcher RA
Contracept Technol Update; 1985 Jan; 6(1):21. PubMed ID: 12279915
[TBL] [Abstract][Full Text] [Related]
36. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
37. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
38. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
39. Fertility after contraception or abortion.
Huggins GR; Cullins VE
Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
[TBL] [Abstract][Full Text] [Related]
40. Contraception for the insulin-dependent diabetic woman: the view from one clinic.
Steel JM; Duncan LJ
Diabetes Care; 1980; 3(4):557-60. PubMed ID: 7006945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
